PeptCell.com
About PeptCell.com
PepTcell’s current priorities are the development of a new class of synthetic vaccines – T and B cell vaccines – against highly mutagenic viruses to prevent Influenza, HIV, Hepatitis B & C, Rotavirus and Chagas infections. In addition the company is working to identify and develop a single vaccine that will be effective against a number of mosquito borne diseases.
